• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OREGON MANUFACTURING PLANT NATURALYTE 2251 2K 2.5CA 1MG GAL; DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OREGON MANUFACTURING PLANT NATURALYTE 2251 2K 2.5CA 1MG GAL; DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) Back to Search Results
Model Number 08-2251-0
Medical Device Problem Code Chemical Problem (2893)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 10/26/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Plant investigation: the customer reported samples were available for return for evaluation, however, as of 11/12/2020, no samples were returned.Samples are not needed to confirm the allegation.A sample retain was tested through a special test request and found to be within specifications.Through other complaint allegations of the same issue for lots: 20lxac056, 20lxac058, and 20lxac076.There were companion samples available for testing, which were tested at both the (b)(6) laboratories.Results were found to be conflicting.Due to the conflicting results found between the laboratories, the (b)(6) test methods were reviewed, and a deficiency was found in the test method pertaining to the sodium and potassium analyte tests.Because of the deficiency found in the test method, it was determined that lot 20lxac049 did not meet release specifications and the allegation conductivity low was confirmed.A product history review was performed.A review of the complaint management system on 11/19/2020 identified 2 additional reported event for lot no.20lxac049 related to conductivity issues.A review of the product inventory records for lot no.20lxac049 indicated that (b)(4) cases of finished product were manufactured on 9/15/20 for distribution with no noted nonconformances.After reviewing the finished product release summary, it was determined that 20lxac049 met release specifications.In conclusion, 20lxac049 release testing was found to be compromised due to the deficient test method.A non-conformance was already opened for allegations of conductivity issues and escalated to a corrective action preventative action (capa).Based on the investigation performed, cause was traced to manufacturing.
 
Event or Problem Description
A hemodialysis (hd) clinic biomedical technician (biomed) reported to fresenius customer service that a lot naturalyte had low conductivity.Upon follow up, the biomed reported that during use, the conductivity was at 10.9.The patient completed the treatment using this product.The patient did not develop any symptoms, adverse events, injuries, or require medical intervention.Per the biomed, 20 cases are affected, and now they are using naturalyte lot 20lxac016 without any issues.The biomed reported that there was no service to the machines, and that they use bicarbonate naturalyte lot number: 20lxac016.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NATURALYTE 2251 2K 2.5CA 1MG GAL
Common Device Name
DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
Manufacturer (Section D)
OREGON MANUFACTURING PLANT
director, quality systems
750 n lallendorf road
oregon OH 43616
MDR Report Key10928809
Report Number3005162618-2020-00126
Device Sequence Number2538524
Product Code KPO
UDI-Device Identifier00840861101696
UDI-Public00840861101696
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
K192017
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,user f
Initial Reporter Occupation Biomedical Engineer
Type of Report Initial
Report Date (Section B) 12/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2022
Device Model Number08-2251-0
Device Catalogue Number08-2251-0
Device Lot Number20LXAC049
Was Device Available for Evaluation? No
Device AgeMO
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/06/2020
Initial Report FDA Received Date12/01/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-